Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -20.04% vs 12.11% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 0.84% vs 2.58% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -45.95% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -10.67% vs -1.94% in Mar 2024
Compare Balance Sheet Results of Beryl Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.09
4.45
0.64
14.38%
Share Warrants & Outstandings
Total Reserve
4.41
-6.44
10.85
168.48%
Shareholder's Funds
9.50
-1.99
11.49
577.39%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.74
8.09
-6.35
-78.49%
Secured Loans
1.74
5.10
-3.36
-65.88%
Unsecured Loans
0.00
2.99
-2.99
-100.00%
Deferred Tax Assets / Liabilities
-0.01
-0.19
0.18
94.74%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.42
0.00
0.42
0.00%
Total Non-Current Liabilities
2.15
7.51
-5.36
-71.37%
Current Liabilities
Trade Payables
1.12
10.22
-9.10
-89.04%
Other Current Liabilities
0.73
2.24
-1.51
-67.41%
Short Term Borrowings
2.34
0.00
2.34
0.00%
Short Term Provisions
0.12
0.59
-0.47
-79.66%
Total Current Liabilities
4.30
13.04
-8.74
-67.02%
Total Liabilities
15.95
18.56
-2.61
-14.06%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
12.93
17.69
-4.76
-26.91%
Less: Accumulated Depreciation
6.92
9.72
-2.80
-28.81%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
6.01
7.97
-1.96
-24.59%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.20
0.40
-0.20
-50.00%
Long Term Loans & Advances
0.23
0.18
0.05
27.78%
Other Non Current Assets
0.48
0.00
0.48
0.00%
Total Non-Current Assets
6.91
8.56
-1.65
-19.28%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1.90
3.31
-1.41
-42.60%
Sundry Debtors
5.46
1.28
4.18
326.56%
Cash and Bank
0.81
0.09
0.72
800.00%
Other Current Assets
0.39
0.00
0.39
0.00%
Short Term Loans and Advances
0.48
5.32
-4.84
-90.98%
Total Current Assets
9.04
10.00
-0.96
-9.60%
Net Current Assets (Including Current Investments)
4.74
-3.03
7.77
256.44%
Total Current Assets Excluding Current Investments
9.04
10.00
-0.96
-9.60%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
15.95
18.56
-2.61
-14.06%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
4.07
7.32
-3.25
-44.40%
Book Value per share (adjusted)
18.66
-4.47
23.13
517.45%
Annual - Borrowings
Borrowings 4.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -20.04% vs 12.11% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 6.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.84% vs 2.58% in Mar 2024
Annual - Investments
Investments 0.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -45.95% in Mar 2024
Annual - Current Assets
Current Assets 9.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -10.67% vs -1.94% in Mar 2024






